This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
25 Apr 2012

Dr. Reddy's Launches Olanzapine Tablets in US Market

Dr. Reddy's Laboratories has launched Olanzapine Tablets, a bioequivalent generic version of ZYPREXA Tablets in the US market.

Dr. Reddy's Laboratories announced yesterday that it has launched Olanzapine Tablets (2.5 mg, 5 mg, 7.5 mg, 10mg, 15 mg), a bioequivalent generic version of ZYPREXA Tablets in the US market on April 23, 2012.

 

Dr. Reddy's Olanzapine Tablets in 20 mg had been awarded a 180-day period of marketing exclusivity in the U.S. on October 26, 2011 which was commercialized through a commercial, manufacture and supply agreement with Teva Pharmaceutical Industries Ltd.

 

The ZYPREXA Tablets brand and generic had combined U.S. sales of approximately $3.28 billion for the most recent twelve months ending January 2012 according to IMS Health.

 

Related News